688621.SS Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (30 bal. 2024 @ 10:00):

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China...

Stats
Dzisiejszy wolumen	1.39M
Średni wolumen	1.09M
Kapitalizacja rynkowa	6.31B
EPS	CNY0 ( 2023-10-30 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	31.84
ATR14	CNY0.0290 (0.05%)

Wolumen Korelacja

Długi: -0.02 (neutral)

Krótki: 0.51 (weak)

Signal:(31.651) Neutral

Beijing Sun-Novo Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Beijing Sun-Novo Korelacja - Waluta/Towar

-0.78
( moderate negative )

-0.61
( weak negative )

0.00
( neutral )

-0.52
( weak negative )

0.77
( moderate )

Beijing Sun-Novo Finanse

Annual	2023
Przychody:	CNY932.12M
Zysk brutto:	CNY528.35M (56.68 %)
EPS:	CNY1.650

FY	2023
Przychody:	CNY932.12M
Zysk brutto:	CNY528.35M (56.68 %)
EPS:	CNY1.650

FY	2022
Przychody:	CNY676.61M
Zysk brutto:	CNY375.46M (55.49 %)
EPS:	CNY1.390

FY	2021
Przychody:	CNY493.65M
Zysk brutto:	CNY263.68M (53.41 %)
EPS:	CNY1.764

Financial Reports:

No articles found.

Beijing Sun-Novo

Beijing Sun-Novo Pharmaceutical Research Co., Ltd., a contract research company, engages in the research and development of chemical drugs and peptide drugs in China. The company offers small molecule chemical generic drugs; peptide products; and drugs for indications, such as impetigo, acne, renal anemia, chronic kidney disease dialysis patient hyper parathyroid hormone, analgesia, and other symptoms. It also provides packaging material compatibility test, impurity research, extract research, migration research, safety evaluation, and other research services; consistency evaluation services; clinical research services; registration consulting and agency services; and range of pharmacokinetics-pharmacodynamics and GLP bioanalysis services, including pharmacokinetic bioanalysis, immunogenic biology analysis, pharmacodynamics, and biomarker bioanalysis services. The company was founded in 2009 and is based in Beijing, China.